|
ATCC
|
|
ATCC12228, ATCC 12228
|
|
FDA strain PCI 1200
|
|
表皮葡萄球菌, Staphylococcus epidermidis
|
|
12228
|
MH培養(yǎng)基、TSB培養(yǎng)基、 TSA培養(yǎng)基
|
|
37 ℃, 有氧
|
|
1
|
|
無
|
藥敏質(zhì)控菌株，用于藥物敏感性測試
|
ATCC12228菌株特點：
ATCC12228是標(biāo)準(zhǔn)的敏感型表皮葡萄球菌菌株，來源于美國FDA臨分離。
是奈替米星（netilmycin）敏感型標(biāo)準(zhǔn)菌種；
是新生霉素（novobiocin）敏感型標(biāo)準(zhǔn)菌種；
是竹桃霉素（oleandomycin）敏感型標(biāo)準(zhǔn)菌種；
是慶大霉素（gentamicin）敏感型標(biāo)準(zhǔn)菌種；
是巴龍霉素（paromomycin aminosidine, catenulin）敏感型標(biāo)準(zhǔn)菌種；
是西蘇霉素、硫酸紫蘇霉素（ sisomicin）敏感型標(biāo)準(zhǔn)菌株；
是新霉素（neomycin）敏感型標(biāo)準(zhǔn)菌種；
是萬古霉素（vancomycin）敏感型標(biāo)準(zhǔn)菌種。
ATCC12228的應(yīng)用：
藥敏試驗 Pharmaceutical
質(zhì)控菌株 Quality control strain
抑制試驗 Inhibition testing
培養(yǎng)基檢測 Media testing
無菌試驗 Sterility testing
食品檢測 Food testing
紙片擴散法試驗 Susceptibility disc testing
參考文獻：
1. European Pharmacopoeia Commission Microbiological assay of antibiotics. Strasbourg, France:European Pharmacopoeia Commission;European Pharmacopoeia EP 2.7.2, 1997
2. U.S. Pharmacopeia General Chapters; <81> Antibiotics-Microbial Assays. Rockville, MD: U.S. Pharmacopeia; USP USP34-NF29, 2011
3. Neomycin in Feeds -- Stahl Microbiological Agar Diffusion Assay. Gaithersburg, MD:AOAC International;AOAC "Official Methods of Analysis of the AOAC International" 998.02.
4. AOAC International Antibiotics in feeds, microbiological methods. Gaithersburg, MD:AOAC International;AOAC "Official Methods of Analysis of the AOAC International" 957.23.
5. Quality Control for Commercially Prepared Microbiological Culture Media; Approved Standard - 3rd Edition. Wayne, PA. Clinical and Laboratory Standards Institute; CLSI M22-A3.
